Manulife (Manufacturers Life Insurance)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $275M | Buy |
554,085
+842
| +0.2% | +$373K | 0.21% | 95 |
|
|
2026
Q1 | $247M | Sell |
553,243
-4,470
| -0.8% | -$2.08M | 0.21% | 100 |
|
|
2025
Q4 | $253M | Buy |
557,713
+47,548
| +9% | +$20.5M | 0.21% | 106 |
|
|
2025
Q3 | $200M | Sell |
510,165
-36,791
| -7% | -$15.4M | 0.16% | 130 |
|
|
2025
Q2 | $244M | Buy |
546,956
+52
| +0% | +$24K | 0.22% | 102 |
|
|
2025
Q1 | $265M | Buy |
546,904
+1,538
| +0.3% | +$717K | 0.25% | 89 |
|
|
2024
Q4 | $220M | Sell |
545,366
-76,859
| -12% | -$35.6M | 0.19% | 116 |
|
|
2024
Q3 | $289M | Sell |
622,225
-11,350
| -2% | -$5.45M | 0.25% | 80 |
|
|
2024
Q2 | $297M | Sell |
633,575
-62,250
| -9% | -$27M | 0.28% | 75 |
|
|
2024
Q1 | $291M | Sell |
695,825
-122,978
| -15% | -$52M | 0.27% | 84 |
|
|
2023
Q4 | $333M | Sell |
818,803
-62,702
| -7% | -$23.2M | 0.2% | 86 |
|
|
2023
Q3 | $307M | Sell |
881,505
-46,912
| -5% | -$16.4M | 0.18% | 92 |
|
|
2023
Q2 | $327M | Buy |
928,417
+16,131
| +2% | +$5.44M | 0.18% | 89 |
|
|
2023
Q1 | $287M | Buy |
912,286
+73,423
| +9% | +$22M | 0.16% | 108 |
|
|
2022
Q4 | $242M | Buy |
838,863
+86,980
| +12% | +$26.5M | 0.15% | 115 |
|
|
2022
Q3 | $218M | Buy |
751,883
+2,088
| +0.3% | +$601K | 0.15% | 115 |
|
|
2022
Q2 | $211M | Buy |
749,795
+111,201
| +17% | +$29.8M | 0.15% | 118 |
|
|
2022
Q1 | $166M | Buy |
638,594
+161,674
| +34% | +$38.4M | 0.11% | 150 |
|
|
2021
Q4 | $105K | Sell |
476,920
-116,047
| -20% | -$22.6M | 0.06% | 242 |
|
|
2021
Q3 | $108M | Sell |
592,967
-5,773
| -1% | -$1.13M | 0.09% | 235 |
|
|
2021
Q2 | $121M | Sell |
598,740
-9,815
| -2% | -$2.05M | 0.1% | 216 |
|
|
2021
Q1 | $131M | Buy |
608,555
+179,847
| +42% | +$39.5M | 0.11% | 195 |
|
|
2020
Q4 | $101M | Buy |
428,708
+183,432
| +75% | +$42.1M | 0.09% | 217 |
|
|
2020
Q3 | $66.7M | Sell |
245,276
-31,450
| -11% | -$8.68M | 0.07% | 266 |
|
|
2020
Q2 | $78.9M | Sell |
276,726
-2,928
| -1% | -$794K | 0.07% | 243 |
|
|
2020
Q1 | $66.5M | Buy |
279,654
+38,355
| +16% | +$8.8M | 0.07% | 241 |
|
|
2019
Q4 | $52.8M | Sell |
241,299
-7,069
| -3% | -$1.43M | 0.06% | 311 |
|
|
2019
Q3 | $41.4M | Buy |
248,368
+9,405
| +4% | +$1.66M | 0.05% | 355 |
|
|
2019
Q2 | $43.8M | Sell |
238,963
-22,329
| -9% | -$3.9M | 0.05% | 341 |
|
|
2019
Q1 | $48.1M | Sell |
261,292
-41,987
| -14% | -$7.76M | 0.05% | 323 |
|
|
2018
Q4 | $50.3M | Sell |
303,279
-13,370
| -4% | -$2.32M | 0.06% | 288 |
|
|
2018
Q3 | $61M | Buy |
316,649
+44,742
| +16% | +$7.97M | 0.06% | 283 |
|
|
2018
Q2 | $46.2M | Buy |
271,907
+23,694
| +10% | +$3.67M | 0.05% | 359 |
|
|
2018
Q1 | $40.5M | Sell |
248,213
-65,168
| -21% | -$10.6M | 0.04% | 389 |
|
|
2017
Q4 | $47M | Buy |
313,381
+33,614
| +12% | +$4.98M | 0.05% | 345 |
|
|
2017
Q3 | $42.5M | Buy |
279,767
+5,530
| +2% | +$832K | 0.05% | 349 |
|
|
2017
Q2 | $35.3M | Buy |
274,237
+3,271
| +1% | +$394K | 0.04% | 393 |
|
|
2017
Q1 | $29.6M | Buy |
270,966
+12,576
| +5% | +$1.11M | 0.04% | 450 |
|
|
2016
Q4 | $19M | Sell |
258,390
-115,663
| -31% | -$9.41M | 0.03% | 507 |
|
|
2016
Q3 | $32.6M | Sell |
374,053
-47,819
| -11% | -$4.52M | 0.05% | 338 |
|
|
2016
Q2 | $36.3M | Sell |
421,872
-100,665
| -19% | -$8.7M | 0.06% | 310 |
|
|
2016
Q1 | $41M | Buy |
522,537
+276,436
| +112% | +$25M | 0.04% | 283 |
|
|
2015
Q4 | $31K | Sell |
246,101
-8,997
| -4% | -$1.09M | 0.03% | 339 |
|
|
2015
Q3 | $26.6K | Buy |
255,098
+9,078
| +4% | +$1.17M | 0.03% | 387 |
|
|
2015
Q2 | $30.4K | Sell |
246,020
-1,847
| -0.7% | -$233K | 0.04% | 351 |
|
|
2015
Q1 | $29.2K | Sell |
247,867
-5,196
| -2% | -$623K | 0.04% | 362 |
|
|
2014
Q4 | $30.1K | Buy |
253,063
+12,263
| +5% | +$1.38M | 0.04% | 319 |
|
|
2014
Q3 | $27K | Buy |
240,800
+648
| +0.3% | +$61.7K | 0.04% | 347 |
|
|
2014
Q2 | $22.7M | Buy |
240,152
+6,223
| +3% | +$436K | 0.03% | 388 |
|
|
2014
Q1 | $16.5K | Buy |
233,929
+6,724
| +3% | +$533K | 0.03% | 479 |
|
|
2013
Q4 | $16.9K | Sell |
227,205
-24,479
| -10% | -$1.7M | 0.03% | 453 |
|
|
2013
Q3 | $19.1K | Sell |
251,684
-27,111
| -10% | -$2.16M | 0.03% | 418 |
|
|
2013
Q2 | $22.3M | Buy |
+278,795
| New | +$20.5M | 0.04% | 344 |
|
Other funds holding VRTX
Manulife (Manufacturers Life Insurance)'s VRTX Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Vertex Pharmaceuticals (VRTX) stake by 0.15% in Q2 2026, buying an estimated $373K and bringing the position to 554,085 shares worth $275M. The position accounts for 0.21% of the portfolio, ranked #95.
Manulife (Manufacturers Life Insurance) first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $333M in Q4 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 554,085 shares of Vertex Pharmaceuticals worth $275M as of Q2 2026.
- Manulife (Manufacturers Life Insurance) bought 842 Vertex Pharmaceuticals shares in Q2 2026, an estimated $373K.
- Vertex Pharmaceuticals made up 0.21% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #95 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Manulife (Manufacturers Life Insurance)'s Vertex Pharmaceuticals position peaked at $333M in Q4 2023.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.